학술논문

Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania.
Document Type
Article
Source
Emerging Infectious Diseases. Jun2014, Vol. 20 Issue 6, p941-949. 9p. 1 Color Photograph, 1 Diagram, 4 Charts, 1 Graph, 1 Map.
Subject
*MALARIA prevention
*AZITHROMYCIN
*TRACHOMA prevention
*TRACHOMA treatment
*DRUG administration
*PARASITEMIA
*POLYMERASE chain reaction
*THERAPEUTICS
Language
ISSN
1080-6040
Abstract
Single-dose mass drug administration of azithromycin (AZT) is underway to eliminate trachoma worldwide. Studies in Ethiopia showed a reduction in all-cause childhood deaths after administration. To examine the effect of single-dose AZ MDA on prevalent malaria infections in a large prospective cohort of children and parents in Dodoma Province, Tanzania, we quantified the temporal prevalence of malaria parasitemia by real-time PCR for 6 months after single-dose AZT. In the first month after treatment but not in subsequent months, Plasmodium falciparum infections were reduced by 73% (95% CI 43%-89%) in treatment versus control villages and differences remained significant (p = 0.00497) in multivariate models with village-level random effects. Genetic sequencing of P. falciparum ribosomal L4 protein showed no mutations associated with AZT resistance. AZT mass drug administration caused a transient, 1-month anti-malarial effect without selecting for P. falciparum ribosomal L4 resistance mutations in a region with a 10-year history of treating trachoma with this drug. [ABSTRACT FROM AUTHOR]